Clinical Trial
[Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment]
[Article in
Italian]
Affiliations
- PMID: 1806811
Item in Clipboard
Clinical Trial
[Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment]
[Article in
Italian]
Minerva Endocrinol.
1991 Jul-Sep.
Abstract
The Authors have done a clinical study on the efficacy of desmopressin (DDAVP) tablets in the treatment of central diabetes insipidus in 13 patients who were previously treated with intranasal DDAVP. A comparison has been made between peroral and intranasal forms of DDAVP measuring the urinary volume and osmolarity daily. The right dosage of DDAVP tablets was between 150 and 600 micrograms/die. The patients showed very good compliance during the 4 weeks of treatment with DDAVP.
Similar articles
-
[Long-term treatment of central diabetes insipidus with oral DDAVP].Minerva Endocrinol. 1992 Oct-Dec;17(4):189-93. Minerva Endocrinol. 1992. PMID: 1308923 Italian.
-
[Clinical evaluation of desmopressin (DDAVP) in diabetes insipidus: solution vs tablets].Minerva Endocrinol. 1992 Jan-Mar;17(1):37-41. Minerva Endocrinol. 1992. PMID: 1495453 Clinical Trial. Italian.
-
[Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus].Minerva Med. 1992 Dec;83(12):805-13. Minerva Med. 1992. PMID: 1491760 Italian.
-
[Central diabetes insipidus in the very young child. Treatment with oral desmopressin].Arch Fr Pediatr. 1988 Dec;45(10):787-90. Arch Fr Pediatr. 1988. PMID: 3071285 Review. French.
-
Vasopressin analog DDAVP in the treatment of diabetes insipidus.Am J Dis Child. 1976 Feb;130(2):166-9. doi: 10.1001/archpedi.1976.02120030056010. Am J Dis Child. 1976. PMID: 766613 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical